Sol-Gel Technologies (SLGL) Accumulated Expenses (2016 - 2018)
Sol-Gel Technologies (SLGL) reported Accumulated Expenses of $1.0 million for Q4 2018, up 13.3% year-over-year from $910000.0 in Q4 2017, and down 29.77% quarter-over-quarter from $1.5 million in Q3 2018.
Sol-Gel Technologies (SLGL) Accumulated Expenses (2016 - 2018) Analysis & Trends
Sol-Gel Technologies (SLGL) has 3 years of Accumulated Expenses data on file, last reported at $1.0 million in Q4 2018.
- Accumulated Expenses for Q4 2018 came in at $1.0 million, up 13.3% year-over-year; the trailing twelve-month figure through Dec 2018 was $1.0 million (up 13.3% YoY), and the FY2018 annual result was $1.0 million, up 13.3% from the prior year.
- Accumulated Expenses eased to $1.0 million in Q4 2018 per SLGL's latest filing, from $1.5 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $3.6 million in Q4 2016 and troughed at $910000.0 in Q4 2017.
- A 3-year average of $1.7 million and a median of $1.5 million in 2018 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2017 and 2018: Accumulated Expenses tumbled 74.88% in 2017, then gained 13.3% in 2018.
- A 3-year view of Accumulated Expenses shows it stood at $3.6 million in 2016, then sank by 74.88% to $910000.0 in 2017, then grew by 13.3% to $1.0 million in 2018.
- Business Quant data shows SLGL's Accumulated Expenses at $1.0 million in Q4 2018, $1.5 million in Q3 2018, and $1.5 million in Q1 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.03 Mn |
| Sep 30, 2018 | 1.47 Mn |
| Mar 31, 2018 | 1.53 Mn |
| Dec 31, 2017 | 910,000.00 |
| Dec 31, 2016 | 3.62 Mn |